Welcome to to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

April 24, 2014

Diagnosis of Multiple Sclerosis

  Downlad PDF   Multiple sclerosis (MS) presents a number of diagnostic challenges. There is no single sign or symptom that is specific to MS and there are a variety of presenting symptoms. Moreover, in the early stages of the disease, MS symptoms are usually transitory and therefore not directly observable by the physician. As […]

Classification of Multiple Sclerosis

  Downlad PDF   Classification of MS The sub-types of MS include:   Relapsing-Remitting MS (RRMS)  85% of patients who develop MS have RRMS Severity varies greatly in from individual to individual. Initial average annual relapse rate of about 2-2.5, dropping to approximately one per year. Frequent relapses, especially at disease onset, considered as poor […]

McDonald criteria for diagnosis of Multiple Sclerosis

  Downlad PDF The 2010 McDonald criteria for diagnosis of multiple sclerosis (MS)1 Clinical Presentation Additional Data Needed 2 or more attacks (relapses) Objective clinical evidence of 2 or more lesions, or of 1 lesion with historical evidence of prior attacka None; no additional tests required. However, additional evidence such as imaging or other test […]

Actelsar HCT

Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredients: Telmisartan/hydrochlorothiazide 40mg/12.5mg, 80mg/12.5mg, 80mg/25mg. Description: White, oval-shaped, capsule-shaped, or oval-shaped tablets marked TH, TH12.5, or TH on one side and 25 on reverse, respectively. Presentation: 40/12.5mg-28, €6.47; 80/12.5mg-28, €8.18; 80/25mg-28, €8.40. Indication: Treatment of essential hypertension when blood pressure not adequately controlled on […]

Aprok

Company: Spectrum-Thea Pharmaceuticals Ltd. Legal category: Prescription. Hospital. Sport permitted. Active ingredient: Cefuroxime 50mg per vial. Description: Powder for solution for injection. Presentation: Vial-10, €100.37. Indication: Prophylaxis of post-operative endophthalmitis after cataract surgery. Pharmacology: Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins, which leads to bacterial cell lysis and death. Dosage: […]

Strontium ranelate (Protelos) and cardiovascular safety

Strontium ranelate (Protelos): New restricted indication and monitoring recommendations due to concerns regarding cardiovascular safety   An EU review coordinated by the European Medicines Agency (EMA) on the benefits and risks of strontium ranelate recently concluded recommending further restrictions in its use. The review which was initiated following concerns about cardiovascular safety was highlighted in […]

Forxiga and type 2 diabetes

Forxiga receives marketing authorisation for treatment of type 2 diabetes   Download PDF AstraZeneca Pharmaceuticals (Ireland) Ltd  wishes to announce that the European Commission has granted marketing authorisation for Forxiga (dapagliflozin) tablets for the treatment of type 2 diabetes. Forxiga tablets are indicated as a once-daily oral medication to improve glycaemic control in adult patients […]

Azyter

Company: Spectrum Thea Pharmaceuticals Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Azithromycin dihydrate 15mg/g. Description: Eye drops. Presentation: 6, €6.28. Indications: Treatment of purulent bacterial conjunctivitis. Treatment of trachomatous conjunctivitis caused by Chlamydia trachomatis. Pharmacology: Azithromycin is a second generation macrolide antibiotic belonging to the azalide group. It inhibits the synthesis of bacterial […]

Beta-Prograne

Company: Tillomed Laboratories Ltd. Legal category: Prescription. GMS. Prohibited in specific sports. Active ingredient: Propranolol hydrochloride 80mg, 160mg. Description: Hard, prolonged-release capsules. 80mg: Opaque white cap and colourless transparent body. 160mg: White gelatin capsules. Presentation:  80mg (HALF BETA-PROGRANE), €4.45; 160mg (BETA-PROGRANE), €4.67. Indications: Control of hypertension. Management of angina, essential tremor and anxiety. Adjunctive management […]

Bosulif ▼

Company: Pfizer Healthcare Ireland. Legal category: Prescription. High Tech. Sport permitted. Active ingredient: Bosutinib (as monohydrate) 100mg, 500mg. Description: Yellow or red oval biconvex, film-coated tablet marked Pfizer on one side and 100 or 500 on reverse, respectively. Presentation: 100mg-28; 500mg-28. Prices on request. Indications: Treatment of chronic phase, accelerated phase, and blast phase Philadelphia […]

Next Page »